MedTrace Logo

The Dose-Response Relationship of Rocuronium in Patients Taking Pyridostigmine

NCT02157545 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-07-19

No results posted yet for this study

Summary

Pyridostigmine is a medication that is used in certain heart rate and blood pressure conditions. This medication, as a side effect, is known to also cause changes in the junction between a nerve and muscle. The changes caused at the nerve muscle junction by pyridostigmine could alter the effect of muscle relaxants (a medication used during surgery and anesthesia). The investigators are conducting this study to see whether patients taking pyridostigmine are more or less sensitive to rocuronium (a muscle relaxing medication used during surgery).

Conditions

  • Muscle Relaxants

Sponsors & Collaborators

  • Shashi Bhatt, MD

    lead OTHER

Principal Investigators

  • Shashi Bhatt, MD · University of Toledo Health Science Campus

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02157545 on ClinicalTrials.gov